Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine versus lidocaine in orthognathic surgery
IRCT20170718035163N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- May 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, double-blind trial of ropivacaine, lidocaine and epinephrine in Dentofacial Abnormality and mandibular prognathism (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Intraoperative opioid use, Intraoperative bleeding and 4 more. Started May 2019; status: completed.
02
Drugs
ropivacainelidocaineepinephrine
03
Conditions
Dentofacial Abnormalitymandibular prognathism
Beyond the preview
Go deeper on IRCT20170718035163N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170718035163N1.